Canopy Growth (CGC) Current Taxes (2021)

Canopy Growth's (CGC) quarterly Current Taxes came in at $6.1 million in Q4 2021, up 15.15% quarter-over-quarter from $5.3 million in Q3 2021.

Canopy Growth (CGC) Current Taxes (2021) Analysis & Trends

Canopy Growth has disclosed Current Taxes across 1 years of filings, most recently posting $6.1 million for Q4 2021.

Current Taxes for Q4 2021 came in at $6.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $6.1 million (changed N/A YoY), and the FY2021 annual result was $10.7 million, changed N/A from the prior year.
Current Taxes came in at $6.1 million for Q4 2021 at Canopy Growth, up from $5.3 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $11.6 million in Q2 2021 to a low of $5.3 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	211.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	4.61 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	22.15 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-
10	Canopy Growth	11.38 Mn	-137.31 Mn	15.39 Mn	-

Download Data